Resolution of Massive Intracoronary Thrombus During Percutaneous Coronary Intervention Utilizing Intensive Pharmacological and Aspiration Strategies.

Authors :: Khalid N
Iantorno M
Shlofmitz E
Case BC
Forrestal BJ
Yerasi C
Ben-Dor I
Waksman R
Source :: Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2020 Feb; Vol. 21 (2), pp. 251-253. Date of Electronic Publication: 2019 Dec 14.
Publication Year :: 2020
Abstract: Competing Interests: Declaration of competing interest Ron Waksman — Advisory Board: Amgen, Boston Scientific, Cardioset, Cardiovascular Systems Inc., Medtronic, Philips, and Pi-Cardia Ltd.; Consultant: Amgen, Biotronik, Boston Scientific, Cardioset, Cardiovascular Systems Inc., Medtronic, Philips, and Pi-Cardia Ltd.; Grant Support: AstraZeneca, Biotronik, Boston Scientific, and Chiesi; Speakers Bureau: AstraZeneca and Chiesi; and Investor: MedAlliance. All other authors have no conflicts of interest to disclose.

Subjects :: Acute Coronary Syndrome diagnostic imaging
Adult
Anticoagulants administration & dosage
Coronary Stenosis diagnostic imaging
Coronary Thrombosis diagnostic imaging
Drug-Eluting Stents
Humans
Male
Suction
Treatment Outcome
Acute Coronary Syndrome therapy
Angioplasty, Balloon, Coronary instrumentation
Coronary Stenosis therapy
Coronary Thrombosis therapy
Platelet Aggregation Inhibitors administration & dosage
Purinergic P2Y Receptor Antagonists administration & dosage
Thrombectomy

Language :: English
ISSN :: 1878-0938
Volume :: 21
Issue :: 2
Database :: MEDLINE
Journal :: Cardiovascular revascularization medicine : including molecular interventions
Publication Type :: Report
Accession number :: 32024610
Full Text :: https://doi.org/10.1016/j.carrev.2019.12.017

Full Text Access

Tools